Vanguard Group Inc. Boosts Stock Holdings in Colgate-Palmolive Company $CL

Vanguard Group Inc. lifted its position in Colgate-Palmolive Company (NYSE:CL) by 0.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 82,921,002 shares of the company’s stock after purchasing an additional 169,313 shares during the period. Vanguard Group Inc. owned about 10.26% of Colgate-Palmolive worth $6,628,705,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. State of New Jersey Common Pension Fund D boosted its stake in shares of Colgate-Palmolive by 5.2% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 269,652 shares of the company’s stock worth $21,556,000 after acquiring an additional 13,266 shares in the last quarter. Mason & Associates Inc acquired a new position in Colgate-Palmolive in the 3rd quarter worth about $661,000. Pacific Point Advisors LLC boosted its position in Colgate-Palmolive by 2.5% during the third quarter. Pacific Point Advisors LLC now owns 17,503 shares of the company’s stock worth $1,399,000 after purchasing an additional 427 shares in the last quarter. Metis Global Partners LLC grew its holdings in Colgate-Palmolive by 8.7% in the third quarter. Metis Global Partners LLC now owns 35,649 shares of the company’s stock valued at $2,850,000 after purchasing an additional 2,861 shares during the period. Finally, Assetmark Inc. raised its stake in shares of Colgate-Palmolive by 9.9% during the 3rd quarter. Assetmark Inc. now owns 23,208 shares of the company’s stock worth $1,855,000 after buying an additional 2,091 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.5%

Shares of Colgate-Palmolive stock opened at $96.61 on Tuesday. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. The stock’s 50 day simple moving average is $84.21 and its 200-day simple moving average is $81.93. The stock has a market cap of $77.87 billion, a P/E ratio of 36.87, a P/E/G ratio of 4.36 and a beta of 0.29. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.91 earnings per share. Analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.2%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Piper Sandler boosted their target price on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. The Goldman Sachs Group reiterated a “buy” rating and issued a $94.00 price objective on shares of Colgate-Palmolive in a report on Saturday, January 31st. Raymond James Financial reduced their target price on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, October 20th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $94.38.

Insider Activity

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. The trade was a 53.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the sale, the chief operating officer directly owned 10,415 shares in the company, valued at approximately $985,363.15. The trade was a 77.07% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 184,683 shares of company stock valued at $17,486,693 over the last three months. 0.41% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.